These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16097999)

  • 21. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
    Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study.
    Ford GA; Oliver PS; Prior JS; Butland RJ; Wilkinson SP
    Postgrad Med J; 1994 May; 70(823):350-4. PubMed ID: 8016006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D; Bagin R; Goldlust B; Major J; Hepburn B
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R; Brecelj J; Homan M; Heuschkel R
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire.
    Numans ME; de Wit NJ
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1049-55. PubMed ID: 12694087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.
    Gardner JD; Sloan S; Miner PB; Robinson M
    Aliment Pharmacol Ther; 2003 Apr; 17(7):945-53. PubMed ID: 12656697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
    Gardner JD; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1381-6. PubMed ID: 15606401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole for asthma with gastro-oesophageal reflux.
    Field SK
    Eur Respir J; 1999 Jun; 13(6):1495. PubMed ID: 10445632
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
    Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
    Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
    Kiljander T; Salomaa ER; Hietanen E; Helenius H; Liippo K; Terho EO
    Respir Med; 2001 May; 95(5):387-92. PubMed ID: 11392580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
    Farup PG; Hovde O; Torp R; Wetterhus S
    Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.
    Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
    Eur Respir J; 2000 Oct; 16(4):633-8. PubMed ID: 11106204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep-related breathing disorders in small children with nocturnal acid gastro-oesophageal reflux.
    Wasilewska J; Kaczmarski M
    Rocz Akad Med Bialymst; 2004; 49():98-102. PubMed ID: 15631322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.